SUNNYVALE, Calif., April 8 /PRNewswire-FirstCall/ -- Cepheid today announced that it will report financial results for its first quarter ended March 31, 2010, on Thursday, April 22, 2010, after the close of the market.
Interested participants and investors may also listen to the live teleconference call by dialing (866) 356-4441 (domestic) or (617) 597-5396 (international), and entering participant code 57219884. A replay will be available for seven days beginning at 4 p.m. Pacific Time. Access numbers for this replay are (888) 286-8010 (domestic) and (617) 801-6888 (international), with participant code 22168742.
Based in Sunnyvale, Calif., Cepheid is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The company’s systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company’s easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. See http://www.cepheid.com for more information.
CONTACT: Media, Jared Tipton, Corporate Communications, +1-408-400-8377,
jared.tipton@cepheid.com; or Investors, Jacquie Ross, Investor Relations,
+1-408-400 8329, investor.relations@cepheid.com, both of Cepheid
Web site: http://www.cepheid.com/
